SCHEMBL1492931

SCHEMBL1492931

CCOc1ccccc1NC(=O)Nc1ccc(-c2ccnc(C)c2)cc1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 6/20 0.65
MEN1 O00255 4/20 0.62
ALDH1A1 P00352 2/20 0.62
NPC1 O15118 2/20 0.62
SMN1; SMN2 Q16637 2/20 0.62
LMNA P02545 2/20 0.62
PABPC1 P11940 1/20 0.57
MAPT P10636 2/20 0.57
RAB9A P51151 2/20 0.55
CASP3 P42574 1/20 0.55
SENP8 Q96LD8 1/20 0.55
SENP7 Q9BQF6 1/20 0.55
SENP6 Q9GZR1 1/20 0.55
CA12 O43570 1/20 0.55
CA1 P00915 1/20 0.55
CA2 P00918 1/20 0.55
CA9 Q16790 1/20 0.55
PSEN1 P49768 5/20 0.55
PSEN2 P49810 5/20 0.55
APH1B Q8WW43 5/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1492892 0.91 NPC1 (0.55) KMT2AMEN1ALDH1A1NPC1SMN1; SMN2
SCHEMBL1492989 0.89 SMN1; SMN2 (0.62) KMT2AMEN1ALDH1A1NPC1SMN1; SMN2
SCHEMBL1492794 0.88 PPIA (0.58) KMT2AMEN1PSEN1PSEN2APH1B
SCHEMBL1492959 0.86 PORCN (0.59) CA12CA1CA2CA9PSEN1
SCHEMBL1492974 0.85 PSEN1 (0.58) KMT2AMEN1SMN1; SMN2MAPTPSEN1
SCHEMBL27809666 0.83 PSEN1 (0.61) KMT2AMEN1NPC1SMN1; SMN2LMNA
SCHEMBL1780926 0.83 PSEN1 (0.61) KMT2AMEN1NPC1SMN1; SMN2MAPT
SCHEMBL1492766 0.83 PSEN1 (0.56) KMT2AMEN1NPC1SMN1; SMN2MAPT
SCHEMBL1492714 0.83 MAPT (0.57) KMT2AMEN1MAPTPSEN1PSEN2
SCHEMBL1492871 0.83 PSEN1 (0.58) PSEN1PSEN2APH1BNCSTNAPH1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110118234-A1 Urea Compounds as Gamma Secretase Modulators AMGEN INC. 2011-05-19 US claimed
EP-2300427-A1 UREA COMPOUNDS AS GAMMA SECRETASE MODULATORS AMGEN INC. (US) 2011-03-30 EP claimed
WO-2009137404-A1 UREA COMPOUNDS AS GAMMA SECRETASE MODULATORS AMGEN INC. (US) 2009-11-12 WO claimed
US-20110118234-A1 Urea Compounds as Gamma Secretase Modulators AMGEN INC. 2011-05-19 US disclosed
US-20110118234-A1 Urea Compounds as Gamma Secretase Modulators AMGEN INC. 2011-05-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110118234-A1 Urea Compounds as Gamma Secretase Modulators BACE1, BACE2, PSEN1 KMT2A 3895/4885MEN1 3122/4885ALDH1A1 2026/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.